Volume 19: Issue 3 (Dec 2020): Disorders of Divalent Ions, Renal Bone Disease and Nephrolithiasis

Mohammad J, Scanni R, Bestmann L, Hulter HN, Krapf R: A controlled increase in dietary phosphate elevates BP in healthy human subjects. J Am Soc Nephrol 29: 2089–2098, 2018 10.1681/ASN.2017121254

• Crossref
Mohammad J, Scanni R, Bestmann L, Hulter HN, Krapf R: A controlled increase in dietary phosphate elevates BP in healthy human subjects. J Am Soc Nephrol 29: 2089–2098, 2018 10.1681/ASN.201712125410.1681/ASN.2017121254)| false
• Search Google Scholar
• Export Citation

Scanni R, vonRotz M, Jehle S, Hulter HN, Krapf R: The human response to acute enteral and parenteral phosphate loads. J Am Soc Nephrol 25: 2730–2739, 2014 10.1681/ASN.2013101076

• Crossref
Scanni R, vonRotz M, Jehle S, Hulter HN, Krapf R: The human response to acute enteral and parenteral phosphate loads. J Am Soc Nephrol 25: 2730–2739, 2014 10.1681/ASN.201310107610.1681/ASN.2013101076)| false
• Search Google Scholar
• Export Citation

Bourgeois S, Capuano P, Stange G, Mühlemann R, Murer H, Biber J, et al..: The phosphate transporter NaPi-IIa determines the rapid renal adaptation to dietary phosphate intake in mouse irrespective of persistently high FGF23 levels. Pflugers Arch 465: 1557–1572, 2013 10.1007/s00424-013-1298-9 PubMed

• Crossref
Bourgeois S, Capuano P, Stange G, Mühlemann R, Murer H, Biber J, .: The phosphate transporter NaPi-IIa determines the rapid renal adaptation to dietary phosphate intake in mouse irrespective of persistently high FGF23 levels. Pflugers Arch 465: 1557–1572, 2013 10.1007/s00424-013-1298-9 PubMed10.1007/s00424-013-1298-9)| false
• Search Google Scholar
• Export Citation

Giral H, Caldas Y, Sutherland E, Wilson P, Breusegem S, Barry N, et al..: Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol 297: F1466–F1475, 2009 10.1152/ajprenal.00279.2009

• Crossref
Giral H, Caldas Y, Sutherland E, Wilson P, Breusegem S, Barry N, .: Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol 297: F1466–F1475, 2009 10.1152/ajprenal.00279.200910.1152/ajprenal.00279.2009)| false
• Search Google Scholar
• Export Citation

Hernando N, Wagner CA: Mechanisms and regulation of intestinal phosphate absorption. Compr Physiol 8: 1065–1090, 2018 10.1002/cphy.c170024 PubMed

• Crossref
Hernando N, Wagner CA: Mechanisms and regulation of intestinal phosphate absorption. Compr Physiol 8: 1065–1090, 2018 10.1002/cphy.c170024 PubMed10.1002/cphy.c170024)| false
• Search Google Scholar
• Export Citation

Pastor-Arroyo EM, Knöpfel T, Imenez Silva PH, Schnitzbauer U, Poncet N, Biber J, et al..: Intestinal epithelial ablation of Pit-2/Slc20a2 in mice leads to sustained elevation of vitamin D3 upon dietary restriction of phosphate. Acta Physiol (Oxf) 230: e13526, 2020 10.1111/apha.13526 PubMed

• Crossref
Pastor-Arroyo EM, Knöpfel T, Imenez Silva PH, Schnitzbauer U, Poncet N, Biber J, .: Intestinal epithelial ablation of Pit-2/Slc20a2 in mice leads to sustained elevation of vitamin D₃ upon dietary restriction of phosphate. Acta Physiol (Oxf) 230: e13526, 2020 10.1111/apha.13526 PubMed10.1111/apha.13526)| false
• Search Google Scholar
• Export Citation

Ichida Y, Ohtomo S, Yamamoto T, Murao N, Tsuboi Y, Kawabe Y, et al..: Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease [published online ahead of print September 3, 2020]. Nephrol Dial Transplant 10.1093/ndt/gfaa156 PubMed

Ichida Y, Ohtomo S, Yamamoto T, Murao N, Tsuboi Y, Kawabe Y, .: Evidence of an intestinal phosphate transporter alternative to type IIb sodium-dependent phosphate transporter in rats with chronic kidney disease [published online ahead of print September 3, 2020]. Nephrol Dial Transplant 10.1093/ndt/gfaa156 PubMed)| false
• Search Google Scholar
• Export Citation

King AJ, Siegel M, He Y, Nie B, Wang J, Koo-McCoy S, et al..: Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Sci Transl Med 10: eaam6474, 2018 10.1126/scitranslmed.aam6474

• Crossref
King AJ, Siegel M, He Y, Nie B, Wang J, Koo-McCoy S, .: Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability. Sci Transl Med 10: eaam6474, 2018 10.1126/scitranslmed.aam647410.1126/scitranslmed.aam6474)| false
• Search Google Scholar
• Export Citation

Cozzolino M, Ketteler M, Wagner CA: An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations. Expert Opin Ther Targets 24: 477–488, 2020 10.1080/14728222.2020.1743680 PubMed

• Crossref
Cozzolino M, Ketteler M, Wagner CA: An expert update on novel therapeutic targets for hyperphosphatemia in chronic kidney disease: preclinical and clinical innovations. Expert Opin Ther Targets 24: 477–488, 2020 10.1080/14728222.2020.1743680 PubMed10.1080/14728222.2020.1743680)| false
• Search Google Scholar
• Export Citation

Wagner CA: Coming out of the PiTs-novel strategies for controlling intestinal phosphate absorption in patients with CKD. Kidney Int 98: 273–275, 2020 10.1016/j.kint.2020.04.010 PubMed

• Crossref
Wagner CA: Coming out of the PiTs-novel strategies for controlling intestinal phosphate absorption in patients with CKD. Kidney Int 98: 273–275, 2020 10.1016/j.kint.2020.04.010 PubMed10.1016/j.kint.2020.04.010)| false
• Search Google Scholar
• Export Citation

Motta SE, Imenez Silva PH, Daryadel A, Haykir B, Pastor-Arroyo EM, Bettoni C, et al..: Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease. Pflugers Arch 472: 449–460, 2020 10.1007/s00424-020-02370-9 PubMed

• Crossref
Motta SE, Imenez Silva PH, Daryadel A, Haykir B, Pastor-Arroyo EM, Bettoni C, .: Expression of NaPi-IIb in rodent and human kidney and upregulation in a model of chronic kidney disease. Pflugers Arch 472: 449–460, 2020 10.1007/s00424-020-02370-9 PubMed10.1007/s00424-020-02370-9)| false
• Search Google Scholar
• Export Citation

Levi M, Gratton E, Forster IC, Hernando N, Wagner CA, Biber J, et al..: Mechanisms of phosphate transport. Nat Rev Nephrol 15: 482–500, 2019 10.1038/s41581-019-0159-y PubMed

• Crossref
Levi M, Gratton E, Forster IC, Hernando N, Wagner CA, Biber J, .: Mechanisms of phosphate transport. Nat Rev Nephrol 15: 482–500, 2019 10.1038/s41581-019-0159-y PubMed10.1038/s41581-019-0159-y)| false
• Search Google Scholar
• Export Citation

Legati A, Giovannini D, Nicolas G, Lopez-Sanchez U, Quintans B, Oliveira JR, et al..: Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat Genet 47: 579–581, 2015 10.1038/ng.3289

• Crossref
Legati A, Giovannini D, Nicolas G, Lopez-Sanchez U, Quintans B, Oliveira JR, .: Mutations in XPR1 cause primary familial brain calcification associated with altered phosphate export. Nat Genet 47: 579–581, 2015 10.1038/ng.328910.1038/ng.3289)| false
• Search Google Scholar
• Export Citation

Anheim M, Lopez-Sanchez U, Giovannini D, Richard AC, Touhami J, N'Guyen L, et al..: XPR1 mutations are a rare cause of primary familial brain calcification. J Neurol 263: 1559–1564, 2016 10.1007/s00415-016-8166-4 10.1007/s00415-016-8166-4

• Crossref
Anheim M, Lopez-Sanchez U, Giovannini D, Richard AC, Touhami J, N'Guyen L, .: XPR1 mutations are a rare cause of primary familial brain calcification. J Neurol 263: 1559–1564, 2016 10.1007/s00415-016-8166-4 10.1007/s00415-016-8166-410.1007/s00415-016-8166-4)| false
• Search Google Scholar
• Export Citation

Ansermet C, Moor MB, Centeno G, Auberson M, Hu DZ, Baron R, et al..: Renal fanconi syndrome and hypophosphatemic rickets in the absence of xenotropic and polytropic retroviral receptor in the nephron. J Am Soc Nephrol 28: 1073–1078, 2017 10.1681/ASN.2016070726

• Crossref
Ansermet C, Moor MB, Centeno G, Auberson M, Hu DZ, Baron R, .: Renal fanconi syndrome and hypophosphatemic rickets in the absence of xenotropic and polytropic retroviral receptor in the nephron. J Am Soc Nephrol 28: 1073–1078, 2017 10.1681/ASN.201607072610.1681/ASN.2016070726)| false
• Search Google Scholar
• Export Citation

Picard N, Capuano P, Stange G, Mihailova M, Kaissling B, Murer H, et al..: Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters. Pflugers Arch 460: 677–687, 2010 10.1007/s00424-010-0841-1 PubMed

• Crossref
Picard N, Capuano P, Stange G, Mihailova M, Kaissling B, Murer H, .: Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters. Pflugers Arch 460: 677–687, 2010 10.1007/s00424-010-0841-1 PubMed10.1007/s00424-010-0841-1)| false
• Search Google Scholar
• Export Citation

Bacic D, Lehir M, Biber J, Kaissling B, Murer H, Wagner CA: The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. Kidney Int 69: 495–503, 2006 10.1038/sj.ki.5000148

• Crossref
Bacic D, Lehir M, Biber J, Kaissling B, Murer H, Wagner CA: The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone. Kidney Int 69: 495–503, 2006 10.1038/sj.ki.500014810.1038/sj.ki.5000148)| false
• Search Google Scholar
• Export Citation

Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, et al..: Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70: 2141–2147, 2006 10.1038/sj.ki.5002000

• Crossref
Nishida Y, Taketani Y, Yamanaka-Okumura H, Imamura F, Taniguchi A, Sato T, .: Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men. Kidney Int 70: 2141–2147, 2006 10.1038/sj.ki.500200010.1038/sj.ki.5002000)| false
• Search Google Scholar
• Export Citation

Thomas L, Bettoni C, Knopfel T, Hernando N, Biber J, Wagner CA: Acute adaption to oral or intravenous phosphate requires parathyroid hormone. J Am Soc Nephrol 28: 903–914, 2017 10.1681/ASN.2016010082

• Crossref
Thomas L, Bettoni C, Knopfel T, Hernando N, Biber J, Wagner CA: Acute adaption to oral or intravenous phosphate requires parathyroid hormone. J Am Soc Nephrol 28: 903–914, 2017 10.1681/ASN.201601008210.1681/ASN.2016010082)| false
• Search Google Scholar
• Export Citation

Michigami T, Kawai M, Yamazaki M, Ozono K: Phosphate as a signaling molecule and its sensing mechanism. Physiol Rev 98: 2317–2348, 2018 10.1152/physrev.00022.2017 PubMed

• Crossref
Michigami T, Kawai M, Yamazaki M, Ozono K: Phosphate as a signaling molecule and its sensing mechanism. Physiol Rev 98: 2317–2348, 2018 10.1152/physrev.00022.2017 PubMed10.1152/physrev.00022.2017)| false
• Search Google Scholar
• Export Citation

Chande S, Bergwitz C: Role of phosphate sensing in bone and mineral metabolism. Nat Rev Endocrinol 14: 637–655, 2018 10.1038/s41574-018-0076-3 PubMed

• Crossref
Chande S, Bergwitz C: Role of phosphate sensing in bone and mineral metabolism. Nat Rev Endocrinol 14: 637–655, 2018 10.1038/s41574-018-0076-3 PubMed10.1038/s41574-018-0076-3)| false
• Search Google Scholar
• Export Citation

Lederer E, Wagner CA: Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: Mutations and disease associations. Pflugers Arch 471: 137–148, 2019 10.1007/s00424-018-2246-5 PubMed

• Crossref
Lederer E, Wagner CA: Clinical aspects of the phosphate transporters NaPi-IIa and NaPi-IIb: Mutations and disease associations. Pflugers Arch 471: 137–148, 2019 10.1007/s00424-018-2246-5 PubMed10.1007/s00424-018-2246-5)| false
• Search Google Scholar
• Export Citation

Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, et al..: A loss-of-function mutation in NaPi-IIa and renal Fanconi’s syndrome. N Engl J Med 362: 1102–1109, 2010 10.1056/NEJMoa0905647

• Crossref
Magen D, Berger L, Coady MJ, Ilivitzki A, Militianu D, Tieder M, .: A loss-of-function mutation in NaPi-IIa and renal Fanconi’s syndrome. N Engl J Med 362: 1102–1109, 2010 10.1056/NEJMoa090564710.1056/NEJMoa0905647)| false
• Search Google Scholar
• Export Citation

Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, et al..: Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol 27: 604–614, 2016 10.1681/ASN.2014101025

• Crossref
Schlingmann KP, Ruminska J, Kaufmann M, Dursun I, Patti M, Kranz B, .: Autosomal-recessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol 27: 604–614, 2016 10.1681/ASN.201410102510.1681/ASN.2014101025)| false
• Search Google Scholar
• Export Citation

Dasgupta D, Wee MJ, Reyes M, Li Y, Simm PJ, Sharma A, et al..: Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. J Am Soc Nephrol 25: 2366–2375, 2014 10.1681/ASN.2013101085

• Crossref
Dasgupta D, Wee MJ, Reyes M, Li Y, Simm PJ, Sharma A, .: Mutations in SLC34A3/NPT2c are associated with kidney stones and nephrocalcinosis. J Am Soc Nephrol 25: 2366–2375, 2014 10.1681/ASN.201310108510.1681/ASN.2013101085)| false
• Search Google Scholar
• Export Citation

Haito-Sugino S, Ito M, Ohi A, Shiozaki Y, Kangawa N, Nishiyama T, et al..: Processing and stability of type IIc sodium-dependent phosphate cotransporter mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria. Am J Physiol Cell Physiol 302: C1316–C1330, 2012 10.1152/ajpcell.00314.2011

• Crossref
Haito-Sugino S, Ito M, Ohi A, Shiozaki Y, Kangawa N, Nishiyama T, .: Processing and stability of type IIc sodium-dependent phosphate cotransporter mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria. Am J Physiol Cell Physiol 302: C1316–C1330, 2012 10.1152/ajpcell.00314.201110.1152/ajpcell.00314.2011)| false
• Search Google Scholar
• Export Citation

Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, et al..: New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376–384, 2010 10.1038/ng.568

• Crossref
Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, .: New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376–384, 2010 10.1038/ng.56810.1038/ng.568)| false
• Search Google Scholar
• Export Citation

Pattaro C, Teumer A, Gorski M, Chu AY, Li M, Mijatovic V, et al..: Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun 7: 10023, 2016 10.1038/ncomms10023

• Crossref
Pattaro C, Teumer A, Gorski M, Chu AY, Li M, Mijatovic V, .: Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. Nat Commun 7: 10023, 2016 10.1038/ncomms1002310.1038/ncomms10023)| false
• Search Google Scholar
• Export Citation

Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, et al..: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41: 712–717, 2009 10.1038/ng.377

• Crossref
Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, .: Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet 41: 712–717, 2009 10.1038/ng.37710.1038/ng.377)| false
• Search Google Scholar
• Export Citation

Oddsson A, Sulem P, Helgason H, Edvardsson VO, Thorleifsson G, Sveinbjornsson G, et al..: Common and rare variants associated with kidney stones and biochemical traits. Nat Commun 6: 7975, 2015 10.1038/ncomms8975

• Crossref
Oddsson A, Sulem P, Helgason H, Edvardsson VO, Thorleifsson G, Sveinbjornsson G, .: Common and rare variants associated with kidney stones and biochemical traits. Nat Commun 6: 7975, 2015 10.1038/ncomms897510.1038/ncomms8975)| false
• Search Google Scholar
• Export Citation

Hernando N: NaPi-IIa interacting partners and their (un)known functional roles. Pflugers Arch 471: 67–82, 2019 10.1007/s00424-018-2176-2 PubMed

• Crossref
Hernando N: NaPi-IIa interacting partners and their (un)known functional roles. Pflugers Arch 471: 67–82, 2019 10.1007/s00424-018-2176-2 PubMed10.1007/s00424-018-2176-2)| false
• Search Google Scholar
• Export Citation

Karim Z, Gerard B, Bakouh N, Alili R, Leroy C, Beck L, et al..: NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359: 1128–1135, 2008 10.1056/NEJMoa0802836

• Crossref
Karim Z, Gerard B, Bakouh N, Alili R, Leroy C, Beck L, .: NHERF1 mutations and responsiveness of renal parathyroid hormone. N Engl J Med 359: 1128–1135, 2008 10.1056/NEJMoa080283610.1056/NEJMoa0802836)| false
• Search Google Scholar
• Export Citation

Cebeci AN, Zou M, BinEssa HA, Alzahrani AS, Al-Rijjal RA, Al-Enezi AF, et al..: Mutation of SGK3, a novel regulator of renal phosphate transport, causes autosomal dominant hypophosphatemic rickets. J Clin Endocrinol Metab 105: dgz260, 2020 10.1210/clinem/dgz260 PubMed

• Crossref
Cebeci AN, Zou M, BinEssa HA, Alzahrani AS, Al-Rijjal RA, Al-Enezi AF, .: Mutation of SGK3, a novel regulator of renal phosphate transport, causes autosomal dominant hypophosphatemic rickets. J Clin Endocrinol Metab 105: dgz260, 2020 10.1210/clinem/dgz260 PubMed10.1210/clinem/dgz260)| false
• Search Google Scholar
• Export Citation

Bhandaru M, Kempe DS, Rotte A, Capuano P, Pathare G, Sopjani M, et al..: Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3. Kidney Int 80: 61–67, 2011 10.1038/ki.2011.67

• Crossref
Bhandaru M, Kempe DS, Rotte A, Capuano P, Pathare G, Sopjani M, .: Decreased bone density and increased phosphaturia in gene-targeted mice lacking functional serum- and glucocorticoid-inducible kinase 3. Kidney Int 80: 61–67, 2011 10.1038/ki.2011.6710.1038/ki.2011.67)| false
• Search Google Scholar
• Export Citation

Marcucci G, Brandi ML: Congenital conditions of hypophosphatemia expressed in adults [published online ahead of print May 14, 2020]. Calcif Tissue Int 10.1007/s00223-020-00695-2 PubMed

Marcucci G, Brandi ML: Congenital conditions of hypophosphatemia expressed in adults [published online ahead of print May 14, 2020]. Calcif Tissue Int 10.1007/s00223-020-00695-2 PubMed)| false
• Search Google Scholar
• Export Citation

Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D: Renal Fanconi syndrome: Taking a proximal look at the nephron. Nephrol Dial Transplant 30: 1456–1460, 2015 10.1093/ndt/gfu377 PubMed

• Crossref
Klootwijk ED, Reichold M, Unwin RJ, Kleta R, Warth R, Bockenhauer D: Renal Fanconi syndrome: Taking a proximal look at the nephron. Nephrol Dial Transplant 30: 1456–1460, 2015 10.1093/ndt/gfu377 PubMed10.1093/ndt/gfu377)| false
• Search Google Scholar
• Export Citation

Hall AM, Bass P, Unwin RJ: Drug-induced renal Fanconi syndrome. QJM 107: 261–269, 2014 10.1093/qjmed/hct258 PubMed

• Crossref
Hall AM, Bass P, Unwin RJ: Drug-induced renal Fanconi syndrome. QJM 107: 261–269, 2014 10.1093/qjmed/hct258 PubMed10.1093/qjmed/hct258)| false
• Search Google Scholar
• Export Citation

Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT: Tumor-induced osteomalacia [published online ahead of print June 5, 2020]. Calcif Tissue Int 10.1007/s00223-020-00691-6 PubMed

Florenzano P, Hartley IR, Jimenez M, Roszko K, Gafni RI, Collins MT: Tumor-induced osteomalacia [published online ahead of print June 5, 2020]. Calcif Tissue Int 10.1007/s00223-020-00691-6 PubMed)| false
• Search Google Scholar
• Export Citation

Baia LC, Heilberg IP, Navis G, de Borst MH; NIGRAM investigators: Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol 11: 656–666, 2015 10.1038/nrneph.2015.153 PubMed

• Crossref
Baia LC, Heilberg IP, Navis G, de Borst MH; NIGRAM investigators: Phosphate and FGF-23 homeostasis after kidney transplantation. Nat Rev Nephrol 11: 656–666, 2015 10.1038/nrneph.2015.153 PubMed10.1038/nrneph.2015.153)| false
• Search Google Scholar
• Export Citation

Payne RB: Renal tubular reabsorption of phosphate (TmP/GFR): Indications and interpretation. Ann Clin Biochem 35: 201–206, 1998 10.1177/000456329803500203 PubMed

• Crossref
Payne RB: Renal tubular reabsorption of phosphate (TmP/GFR): Indications and interpretation. Ann Clin Biochem 35: 201–206, 1998 10.1177/000456329803500203 PubMed10.1177/000456329803500203)| false
• Search Google Scholar
• Export Citation

Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D; ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group: The role of phosphate in kidney disease. Nat Rev Nephrol 13: 27–38, 2017 10.1038/nrneph.2016.164 PubMed

• Crossref
Vervloet MG, Sezer S, Massy ZA, Johansson L, Cozzolino M, Fouque D; ERA–EDTA Working Group on Chronic Kidney Disease–Mineral and Bone Disorders and the European Renal Nutrition Working Group: The role of phosphate in kidney disease. Nat Rev Nephrol 13: 27–38, 2017 10.1038/nrneph.2016.164 PubMed10.1038/nrneph.2016.164)| false
• Search Google Scholar
• Export Citation

Yoo KD, Kang S, Choi Y, Yang SH, Heo NJ, Chin HJ, et al..: Sex, age, and the association of serum phosphorus with all-cause mortality in adults with normal kidney function. Am J Kidney Dis 67: 79–88, 2016 10.1053/j.ajkd.2015.06.027

• Crossref
Yoo KD, Kang S, Choi Y, Yang SH, Heo NJ, Chin HJ, .: Sex, age, and the association of serum phosphorus with all-cause mortality in adults with normal kidney function. Am J Kidney Dis 67: 79–88, 2016 10.1053/j.ajkd.2015.06.02710.1053/j.ajkd.2015.06.027)| false
• Search Google Scholar
• Export Citation

Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, et al..: Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120: 1784–1792, 2009 10.1161/CIRCULATIONAHA.109.851873

• Crossref
Tonelli M, Curhan G, Pfeffer M, Sacks F, Thadhani R, Melamed ML, .: Relation between alkaline phosphatase, serum phosphate, and all-cause or cardiovascular mortality. Circulation 120: 1784–1792, 2009 10.1161/CIRCULATIONAHA.109.85187310.1161/CIRCULATIONAHA.109.851873)| false
• Search Google Scholar
• Export Citation

Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol and Recurrent Events Trial Investigators: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627–2633, 2005 10.1161/CIRCULATIONAHA.105.553198 PubMed

• Crossref
Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G; Cholesterol and Recurrent Events Trial Investigators: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627–2633, 2005 10.1161/CIRCULATIONAHA.105.553198 PubMed10.1161/CIRCULATIONAHA.105.553198)| false
• Search Google Scholar
• Export Citation

Dhingra R, Gona P, Benjamin EJ, Wang TJ, Aragam J, D'Agostino RB, Sr., et al..: Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail 12: 812–818, 2010 10.1093/eurjhf/hfq106

• Crossref
Dhingra R, Gona P, Benjamin EJ, Wang TJ, Aragam J, D'Agostino RB, Sr., .: Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community. Eur J Heart Fail 12: 812–818, 2010 10.1093/eurjhf/hfq10610.1093/eurjhf/hfq106)| false
• Search Google Scholar
• Export Citation

Sim JJ, Bhandari SK, Smith N, Chung J, Liu IL, Jacobsen SJ, et al..: Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med 126: 311–318, 2013 10.1016/j.amjmed.2012.08.018 PubMed

• Crossref
Sim JJ, Bhandari SK, Smith N, Chung J, Liu IL, Jacobsen SJ, .: Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med 126: 311–318, 2013 10.1016/j.amjmed.2012.08.018 PubMed10.1016/j.amjmed.2012.08.018)| false
• Search Google Scholar
• Export Citation

Chang AR, Lazo M, Appel LJ, Gutierrez OM, Grams ME: High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III. Am J Clin Nutr 99: 320–327, 2014 10.3945/ajcn.113.073148

• Crossref
Chang AR, Lazo M, Appel LJ, Gutierrez OM, Grams ME: High dietary phosphorus intake is associated with all-cause mortality: Results from NHANES III. Am J Clin Nutr 99: 320–327, 2014 10.3945/ajcn.113.07314810.3945/ajcn.113.073148)| false
• Search Google Scholar
• Export Citation

Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, et al..: Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: A sequence suggested from a cross-sectional study. Nephrol Dial Transplant 28: 352–359, 2013 10.1093/ndt/gfs460

• Crossref
Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, .: Secreted Klotho and FGF23 in chronic kidney disease stage 1 to 5: A sequence suggested from a cross-sectional study. Nephrol Dial Transplant 28: 352–359, 2013 10.1093/ndt/gfs46010.1093/ndt/gfs460)| false
• Search Google Scholar
• Export Citation

Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, et al..: Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79: 1370–1378, 2011 10.1038/ki.2011.47

• Crossref
Isakova T, Wahl P, Vargas GS, Gutierrez OM, Scialla J, Xie H, .: Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79: 1370–1378, 2011 10.1038/ki.2011.4710.1038/ki.2011.47)| false
• Search Google Scholar
• Export Citation

Hu MC, Shiizaki K, Kuro-o M, Moe OW: Fibroblast growth factor 23 and Klotho: Physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75: 503–533, 2013 10.1146/annurev-physiol-030212-183727 PubMed

• Crossref
Hu MC, Shiizaki K, Kuro-o M, Moe OW: Fibroblast growth factor 23 and Klotho: Physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75: 503–533, 2013 10.1146/annurev-physiol-030212-183727 PubMed10.1146/annurev-physiol-030212-183727)| false
• Search Google Scholar
• Export Citation

Dhayat NA, Ackermann D, Pruijm M, Ponte B, Ehret G, Guessous I, et al..: Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int 90: 648–657, 2016 10.1016/j.kint.2016.04.024

• Crossref
Dhayat NA, Ackermann D, Pruijm M, Ponte B, Ehret G, Guessous I, .: Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function. Kidney Int 90: 648–657, 2016 10.1016/j.kint.2016.04.02410.1016/j.kint.2016.04.024)| false
• Search Google Scholar
• Export Citation

Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, et al..: Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation. Kidney Int 96: 890–905, 2019 10.1016/j.kint.2019.04.009 PubMed

• Crossref
Egli-Spichtig D, Imenez Silva PH, Glaudemans B, Gehring N, Bettoni C, Zhang MYH, .: Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation. Kidney Int 96: 890–905, 2019 10.1016/j.kint.2019.04.009 PubMed10.1016/j.kint.2019.04.009)| false
• Search Google Scholar
• Export Citation

Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T: Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int 94: 315–325, 2018 10.1016/j.kint.2018.02.026 PubMed

• Crossref
Durlacher-Betzer K, Hassan A, Levi R, Axelrod J, Silver J, Naveh-Many T: Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease. Kidney Int 94: 315–325, 2018 10.1016/j.kint.2018.02.026 PubMed10.1016/j.kint.2018.02.026)| false
• Search Google Scholar
• Export Citation

Shalhoub V, Shatzen EM, Ward SC, Davis J, Stevens J, Bi V, et al..: FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 122: 2543–2553, 2012 10.1172/JCI61405

• Crossref
Shalhoub V, Shatzen EM, Ward SC, Davis J, Stevens J, Bi V, .: FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality. J Clin Invest 122: 2543–2553, 2012 10.1172/JCI6140510.1172/JCI61405)| false
• Search Google Scholar
• Export Citation

Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, et al..: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584–592, 2008 10.1056/NEJMoa0706130

• Crossref
Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, .: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359: 584–592, 2008 10.1056/NEJMoa070613010.1056/NEJMoa0706130)| false
• Search Google Scholar
• Export Citation

Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, et al..: Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: A meta-analysis. J Am Soc Nephrol 29: 2015–2027, 2018 10.1681/ASN.2017121334

• Crossref
Marthi A, Donovan K, Haynes R, Wheeler DC, Baigent C, Rooney CM, .: Fibroblast growth factor-23 and risks of cardiovascular and noncardiovascular diseases: A meta-analysis. J Am Soc Nephrol 29: 2015–2027, 2018 10.1681/ASN.201712133410.1681/ASN.2017121334)| false
• Search Google Scholar
• Export Citation

Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, et al..: FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393–4408, 2011 10.1172/JCI46122

• Crossref
Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, .: FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393–4408, 2011 10.1172/JCI4612210.1172/JCI46122)| false
• Search Google Scholar
• Export Citation

Wagner CA, Rubio-Aliaga I, Egli-Spichtig D: Fibroblast growth factor 23 in chronic kidney disease: What is its role in cardiovascular disease? Nephrol Dial Transplant 34: 1986–1990, 2019 10.1093/ndt/gfz044 PubMed

• Crossref
Wagner CA, Rubio-Aliaga I, Egli-Spichtig D: Fibroblast growth factor 23 in chronic kidney disease: What is its role in cardiovascular disease? Nephrol Dial Transplant 34: 1986–1990, 2019 10.1093/ndt/gfz044 PubMed10.1093/ndt/gfz044)| false
• Search Google Scholar
• Export Citation

Pastor-Arroyo EM, Gehring N, Krudewig C, Costantino S, Bettoni C, Knöpfel T, et al..: The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk. Kidney Int 94: 49–59, 2018 10.1016/j.kint.2018.02.017 PubMed

• Crossref
Pastor-Arroyo EM, Gehring N, Krudewig C, Costantino S, Bettoni C, Knöpfel T, .: The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk. Kidney Int 94: 49–59, 2018 10.1016/j.kint.2018.02.017 PubMed10.1016/j.kint.2018.02.017)| false
• Search Google Scholar
• Export Citation